Cargando…
Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis
Nanotechnology could improve our understanding of the pathophysiology of atherosclerosis and contribute to the development of novel diagnostic and therapeutic strategies to further reduce the risk of cardiovascular disease. Macrophages have key roles in atherosclerosis progression and, therefore, ma...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580169/ https://www.ncbi.nlm.nih.gov/pubmed/34759324 http://dx.doi.org/10.1038/s41569-021-00629-x |
_version_ | 1784596557796999168 |
---|---|
author | Chen, Wei Schilperoort, Maaike Cao, Yihai Shi, Jinjun Tabas, Ira Tao, Wei |
author_facet | Chen, Wei Schilperoort, Maaike Cao, Yihai Shi, Jinjun Tabas, Ira Tao, Wei |
author_sort | Chen, Wei |
collection | PubMed |
description | Nanotechnology could improve our understanding of the pathophysiology of atherosclerosis and contribute to the development of novel diagnostic and therapeutic strategies to further reduce the risk of cardiovascular disease. Macrophages have key roles in atherosclerosis progression and, therefore, macrophage-associated pathological processes are important targets for both diagnostic imaging and novel therapies for atherosclerosis. In this Review, we highlight efforts in the past two decades to develop imaging techniques and to therapeutically manipulate macrophages in atherosclerotic plaques with the use of rationally designed nanoparticles. We review the latest progress in nanoparticle-based imaging modalities that can specifically target macrophages. Using novel molecular imaging technology, these modalities enable the identification of advanced atherosclerotic plaques and the assessment of the therapeutic efficacy of medical interventions. Additionally, we provide novel perspectives on how macrophage-targeting nanoparticles can deliver a broad range of therapeutic payloads to atherosclerotic lesions. These nanoparticles can suppress pro-atherogenic macrophage processes, leading to improved resolution of inflammation and stabilization of plaques. Finally, we propose future opportunities for novel diagnostic and therapeutic strategies and provide solutions to challenges in this area for the purpose of accelerating the clinical translation of nanomedicine for the treatment of atherosclerotic vascular disease. |
format | Online Article Text |
id | pubmed-8580169 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-85801692021-11-12 Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis Chen, Wei Schilperoort, Maaike Cao, Yihai Shi, Jinjun Tabas, Ira Tao, Wei Nat Rev Cardiol Review Article Nanotechnology could improve our understanding of the pathophysiology of atherosclerosis and contribute to the development of novel diagnostic and therapeutic strategies to further reduce the risk of cardiovascular disease. Macrophages have key roles in atherosclerosis progression and, therefore, macrophage-associated pathological processes are important targets for both diagnostic imaging and novel therapies for atherosclerosis. In this Review, we highlight efforts in the past two decades to develop imaging techniques and to therapeutically manipulate macrophages in atherosclerotic plaques with the use of rationally designed nanoparticles. We review the latest progress in nanoparticle-based imaging modalities that can specifically target macrophages. Using novel molecular imaging technology, these modalities enable the identification of advanced atherosclerotic plaques and the assessment of the therapeutic efficacy of medical interventions. Additionally, we provide novel perspectives on how macrophage-targeting nanoparticles can deliver a broad range of therapeutic payloads to atherosclerotic lesions. These nanoparticles can suppress pro-atherogenic macrophage processes, leading to improved resolution of inflammation and stabilization of plaques. Finally, we propose future opportunities for novel diagnostic and therapeutic strategies and provide solutions to challenges in this area for the purpose of accelerating the clinical translation of nanomedicine for the treatment of atherosclerotic vascular disease. Nature Publishing Group UK 2021-11-10 2022 /pmc/articles/PMC8580169/ /pubmed/34759324 http://dx.doi.org/10.1038/s41569-021-00629-x Text en © Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Article Chen, Wei Schilperoort, Maaike Cao, Yihai Shi, Jinjun Tabas, Ira Tao, Wei Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis |
title | Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis |
title_full | Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis |
title_fullStr | Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis |
title_full_unstemmed | Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis |
title_short | Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis |
title_sort | macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580169/ https://www.ncbi.nlm.nih.gov/pubmed/34759324 http://dx.doi.org/10.1038/s41569-021-00629-x |
work_keys_str_mv | AT chenwei macrophagetargetednanomedicineforthediagnosisandtreatmentofatherosclerosis AT schilperoortmaaike macrophagetargetednanomedicineforthediagnosisandtreatmentofatherosclerosis AT caoyihai macrophagetargetednanomedicineforthediagnosisandtreatmentofatherosclerosis AT shijinjun macrophagetargetednanomedicineforthediagnosisandtreatmentofatherosclerosis AT tabasira macrophagetargetednanomedicineforthediagnosisandtreatmentofatherosclerosis AT taowei macrophagetargetednanomedicineforthediagnosisandtreatmentofatherosclerosis |